French parliamentary committee to thrash out compromise on regulatory reform
This article was originally published in SRA
Executive Summary
The French government is setting up a committee to look at the bill on drug regulatory reform and produce a text that can be accepted by both houses of parliament, after the Senate approved an amended version of the bill on 27 October1,2.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.